Sunflower Pharmaceutical: Application for Marketing Authorization of Ambroxol Hydrochloride Oral Solution Accepted
Kweihua Pharmaceutical's subsidiary has received acceptance for its application to market Ambroxol Hydrochloride Oral Solution. The drug is intended for conditions involving viscous sputum and difficulty expectorating, such as acute and chronic bronchitis. This marks a step forward in the company's drug development pipeline. AI